Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study

Benutzer: Gast

Titel:: Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Yu, Evan Y.; Kolinsky, Michael P.; Berry, William R.; Retz, Margitta; Mourey, Loic; Piulats, Josep M.; Appleman, Leonard J.; Romano, Emanuela; Gravis, Gwenaelle; Gurney, Howard; Bögemann, Martin; Emmenegger, Urban; Joshua, Anthony M.; Linch, Mark; Sridhar, Srikala; Conter, Henry J.; Laguerre, Brigitte; Massard, Christophe; Li, Xin Tong; Schloss, Charles; Poehlein, Christian H.; de Bono, Johann S.
Zeitschriftentitel:: European Urology
Jahr:: 2022
Band / Volume:: 82
Heft / Issue:: 1
Seitenangaben Beitrag:: 22-30
Volltext / DOI:: doi:10.1016/j.eururo.2022.02.023
Verlag / Institution:: Elsevier BV
E-ISSN:: 0302-2838
Publikationsdatum:: 01.07.2022
BibTeX

Vorkommen: